ENTRY       D11015            Mixture   Drug
NAME        Meropenem and vaborbactam;
            Vabomere (TN)
  ABBR      MVB
PRODUCT     VABOMERE (Melinta Therapeutics)
COMPONENT   (Meropenem [DR:D02222] | Meropenem [DR:D08185]), Vaborbactam [DR:D10998]
REMARK      ATC code: J01DH52
            Product: D11015<US>
EFFICACY    Antibacterial
COMMENT     Treatment of complicated urinary tract infections
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J01 ANTIBACTERIALS FOR SYSTEMIC USE
               J01D OTHER BETA-LACTAM ANTIBACTERIALS
                J01DH Carbapenems
                 J01DH52 Meropenem and vaborbactam
                  D11015  Meropenem and vaborbactam &lt;US&gt;
            USP drug classification [BR:br08302]
             Antibacterials
              Carbapenems
               Meropenem/ Vaborbactam
                D11015  Meropenem and vaborbactam
            Antimicrobials [BR:br08307]
             Antibacterials
              Cell wall biosynthesis inhibitor, beta-lactam
               Carbapenem
                D11015  Meropenem and vaborbactam &lt;US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antibacterials
              Cell wall biosynthesis inhibitor, beta-lactam
               Carbapenem
                D11015  Meropenem and vaborbactam
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11015
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11015
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11015
DBLINKS     PubChem: 348350487
///
